The Patent Finder

Avant Immunotherapeutics, Inc.

Also on record
Records under this name other than patents Avant Immunotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Avant Immunotherapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,841,373Herpes virus complementing cell line
Formerly held
Term ended
Term ended Apr 22, 2021 · USPTO record
Term endedTerm ended Apr 22, 2021USPTO record
US 8,287,855V. cholerae hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
Formerly held
Lapsed on the fee record
Ended Oct 16, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 16, 2020USPTO record
US 6,780,405Regulated antigen delivery system (RADS)
Formerly held
Term ended
Term ended Apr 28, 2020 · USPTO record
Term endedTerm ended Apr 28, 2020USPTO record
US 7,341,860Regulated Antigen Delivery System (RADS)
Formerly held
Lapsed on the fee record
Ended Mar 11, 2020 · Medium confidence
Lapsed on the fee recordEnded Mar 11, 2020Medium confidence
US 6,261,573Immunoadjuvants
Term ended
Term ended Oct 25, 2019 · USPTO record
Term endedTerm ended Oct 25, 2019USPTO record
US 7,871,604Recombinant bacterial vaccine system with environmentally limited viability
Formerly held
Lapsed on the fee record
Ended Jan 18, 2019 · USPTO record
Lapsed on the fee recordEnded Jan 18, 2019USPTO record
US 6,316,604Human C3b/C4b receptor (CR1)
Formerly held
Term ended
Term ended Nov 13, 2018 · USPTO record
Term endedTerm ended Nov 13, 2018USPTO record
US 6,015,563Polyphosphazene polyelectrolyte immunoadjuvants
Term ended
Term ended Nov 4, 2018 · USPTO record
Term endedTerm ended Nov 4, 2018USPTO record
US 6,610,529Recombinant bacterial system with environmentally limited viability
Formerly held
Term ended
Term ended Jun 7, 2015 · USPTO record
Term endedTerm ended Jun 7, 2015USPTO record
US 6,479,284Humanized antibody and uses thereof
Formerly held
Lapsed on the fee record
Ended Nov 12, 2014 · USPTO record
Lapsed on the fee recordEnded Nov 12, 2014USPTO record
10 of 47 patents shown.
Pro members see all 47.
Pro members: see all 47 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited